Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SOPHiA GENETICS (SOPH) Profit After Tax (2020 - 2025)

Historic Profit After Tax for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to -$20.0 million.

  • SOPHiA GENETICS's Profit After Tax fell 858.55% to -$20.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$75.0 million, marking a year-over-year decrease of 501.86%. This contributed to the annual value of -$62.5 million for FY2024, which is 2087.59% up from last year.
  • Latest data reveals that SOPHiA GENETICS reported Profit After Tax of -$20.0 million as of Q3 2025, which was down 858.55% from -$22.4 million recorded in Q2 2025.
  • In the past 5 years, SOPHiA GENETICS's Profit After Tax registered a high of -$12.7 million during Q1 2021, and its lowest value of -$25.5 million during Q1 2022.
  • Over the past 5 years, SOPHiA GENETICS's median Profit After Tax value was -$19.7 million (recorded in 2023), while the average stood at -$19.1 million.
  • The largest annual percentage gain for SOPHiA GENETICS's Profit After Tax in the last 5 years was 9979.7% (2021), contrasted with its biggest fall of 10393.09% (2021).
  • SOPHiA GENETICS's Profit After Tax (Quarter) stood at -$21.4 million in 2021, then surged by 34.64% to -$14.0 million in 2022, then tumbled by 72.21% to -$24.1 million in 2023, then surged by 37.0% to -$15.2 million in 2024, then plummeted by 32.08% to -$20.0 million in 2025.
  • Its Profit After Tax stands at -$20.0 million for Q3 2025, versus -$22.4 million for Q2 2025 and -$17.4 million for Q1 2025.